DR-TB Drugs Under the Microscope: 4th edition
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to standardised questionnaires and the Global TB Drug Facility website.
REPORT UPDATE JULY 2016: This report was published in March 2016, just before the Stop TB Partnership’s Global Drug Facility was due to update its price list for DR-TB drugs. Updated pricing information for regimens and drugs is now available: UPDATE_MSF_REPORT_DR-TB_DRUGS_UTM_JUL_2016.pdf